SAS in Patients With Bronchial Carcinoma (SAS CA)

RWTH Aachen University

Status: Unknown

Conditions: Sleep Apnea Syndrome; Bronchial Carcinoma

Treatments: Device: sleep apnea screening with ApneaLinkTM

Study type: Interventional

Funder types: Other

Identifiers

NCT02270853

13-136

Details and patient eligibility

About

In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.

Full description

Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and
• Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.

Exclusion criteria

• Pregnancy
• other already known malignancies or tumors
• Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

sleep apnea screening with ApneaLinkTM

Other group

Description:

This is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.

Treatment:

Device: sleep apnea screening with ApneaLinkTM